VASAMED, Inc.
VSMD
$0.00
$0.000.00%
OTC PK
| 06/30/2009 | 03/31/2009 | 12/31/2008 | 09/30/2008 | 06/30/2008 | |
|---|---|---|---|---|---|
| Revenue | 29.45% | 48.14% | 0.26% | -13.00% | -9.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.45% | 48.14% | 0.26% | -13.00% | -9.09% |
| Cost of Revenue | -6.86% | -1.60% | -21.40% | -16.80% | -12.66% |
| Gross Profit | 81.10% | 134.98% | 29.22% | -7.67% | -3.45% |
| SG&A Expenses | -33.81% | -26.30% | -10.50% | 0.38% | 4.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.96% | -18.91% | -15.76% | -8.69% | -4.10% |
| Operating Income | 60.29% | 55.23% | 28.80% | 5.20% | 0.57% |
| Income Before Tax | 59.43% | 60.25% | 48.03% | 39.00% | 24.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 59.43% | 60.25% | 48.03% | 39.00% | 24.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.43% | 60.25% | 48.03% | 39.00% | 24.15% |
| EBIT | 60.29% | 55.23% | 28.80% | 5.20% | 0.57% |
| EBITDA | 62.23% | 57.15% | 29.88% | 5.41% | 0.35% |
| EPS Basic | 70.44% | 75.64% | 71.93% | 71.22% | 50.89% |
| Normalized Basic EPS | 70.43% | 75.64% | 71.95% | 70.67% | 49.95% |
| EPS Diluted | 70.44% | 75.64% | 71.93% | 71.22% | 50.89% |
| Normalized Diluted EPS | 70.43% | 75.64% | 71.95% | 70.67% | 49.95% |
| Average Basic Shares Outstanding | 14.90% | 35.03% | 63.69% | 107.82% | 80.86% |
| Average Diluted Shares Outstanding | 14.90% | 35.03% | 63.69% | 107.82% | 80.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |